EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

35 416 2024

Submission to First Decision = 31 Days

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

*

Recommendation for treatment of hepatitis C virus infection

Sabahattin Kaymakoğlu ¹ , İftihar Köksal ¹ , Fehmi Tabak ¹ , Ulus S. Akarca ¹ , Ayhan Akbulut ¹ , Filiz Akyüz ¹ , Hürrem Bodur ¹ , Atahan Çağatay ¹ , Dinç Dinçer ¹ , Şaban Esen ¹ , Rahmet Güner ¹ , Selim Gürel ¹ , Şükran Köse ¹ , Ömer Şentürk ¹ , Halis Şimşek ¹ , Tansu Yamazhan ¹ , Yusuf Yılmaz ¹ , Ramazan Idilman ¹ , and Viral Hepatisis Guideline Study Group ¹

Author Affiliation(s)

1.

Turkish Association for the Study of the Liver, İstanbul, Turkey; Viral Hepatitis Society, Ankara, Turkey

Turk J Gastroenterol 2017; 28: Supplement 94-100

DOI: 10.5152/tjg.2017.22

Read: 2187 Downloads: 1123 Published: 25 July 2019

Volume 28, Issue 2, December 2017

Previous Article

Abstract

Cite this article as: Kaymakoğlu S, Köksal İ, Idilman R; Viral Hepatitis Guidelines Study Group. Recommendation for treatment of hepatitis C virus infection. Turk J Gastroenterol 2017; 28(Suppl 2); SX-SX.

Files